Pei Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pei Nie has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Guangjie Yang
PET Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
6 shared publications Yanmei Wang
GE Healthcare China, Beijing, China
6 shared publicationsHe Zhu
Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China
4 shared publicationsShuo Zhang
Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China
4 shared publications- Wenjian Xu
Department of Radiology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Rd, Shinan District, Qingdao 266003, Shandong, China
4 shared publications Xia Zhao
Department of Radiology, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
4 shared publications
Latest Publications
- 9 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
18F-FAPI PET/CT and Cardiac Magnetic Resonance for Cardiac Fibrotic Process in End-stage Renal Disease
Background: End-stage renal disease (ESRD) increases the risk of myocardial fibrosis. This study aimed to detect cardiac fibroblast activation and fibrosis in ESRD using 18 F-labeled fibroblast activation protein inhibitor (FAPI) PET/CT and cardiac magnetic resonance (CMR). Patients and Methods: This prospective clinical trial (NCT07107919) enrolled 33 ESRD patients who underwent 18 F-FAPI PET/CT, with 19 patients undergoing CMR. Myocardial FAPI activity was quantified. Cardiac function [left ventricular ejection fraction (LVEF), right ventricular ejection fraction (RVEF), left atrial ejection fraction (LAEF)] and tissue parameters [native T1, extracellular volume (ECV), late gadolinium enhancement (LGE)] were assessed by CMR. Spearman correlation analysis assessed correlations between 18 F-FAPI uptake and CMR parameters. Results: A total of 75.76% (25/33) of ESRD patients showed myocardial FAPI uptake, significantly higher than the controls ( P < 0.05). 18 F-FAPI-42 PET identified more segments with evidence of fibroblast activation than CMR-late gadolinium enhancement detected fibrosis (82 vs. 71). Compared with FAPI-negative patients, FAPI-positive patients had increased native-T1, decreased LVEF, LAEF and RVEF ( P < 0.05). FAPI-positive segments showed higher native-T1 and extracellular volume % than FAPI-negative segments ( P < 0.05). FAPI activity correlated with LVEF, RVEF, LAEF and native-T1. Higher myocardial FAPI uptake was associated with lower LVEF and longer dialysis duration. Conclusions: 18 F-FAPI PET enables in vivo detection of cardiac fibroblast activation in ESRD and correlates with functional and tissue parameters by CMR. FAPI uptake may serve as an imaging biomarker for cardiac remodeling. Further studies are warranted to clarify the role of 18 F-FAPI PET in evaluating the efficacy of anti-fibrotic treatment and in assisting cardiac risk stratification in ESRD patients.
- 9 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
18F-FAPI PET/CT and Cardiac Magnetic Resonance for Cardiac Fibrotic Process in End-stage Renal Disease
Background: End-stage renal disease (ESRD) increases the risk of myocardial fibrosis. This study aimed to detect cardiac fibroblast activation and fibrosis in ESRD using 18 F-labeled fibroblast activation protein inhibitor (FAPI) PET/CT and cardiac magnetic resonance (CMR). Patients and Methods: This prospective clinical trial (NCT07107919) enrolled 33 ESRD patients who underwent 18 F-FAPI PET/CT, with 19 patients undergoing CMR. Myocardial FAPI activity was quantified. Cardiac function [left ventricular ejection fraction (LVEF), right ventricular ejection fraction (RVEF), left atrial ejection fraction (LAEF)] and tissue parameters [native T1, extracellular volume (ECV), late gadolinium enhancement (LGE)] were assessed by CMR. Spearman correlation analysis assessed correlations between 18 F-FAPI uptake and CMR parameters. Results: A total of 75.76% (25/33) of ESRD patients showed myocardial FAPI uptake, significantly higher than the controls ( P < 0.05). 18 F-FAPI-42 PET identified more segments with evidence of fibroblast activation than CMR-late gadolinium enhancement detected fibrosis (82 vs. 71). Compared with FAPI-negative patients, FAPI-positive patients had increased native-T1, decreased LVEF, LAEF and RVEF ( P < 0.05). FAPI-positive segments showed higher native-T1 and extracellular volume % than FAPI-negative segments ( P < 0.05). FAPI activity correlated with LVEF, RVEF, LAEF and native-T1. Higher myocardial FAPI uptake was associated with lower LVEF and longer dialysis duration. Conclusions: 18 F-FAPI PET enables in vivo detection of cardiac fibroblast activation in ESRD and correlates with functional and tissue parameters by CMR. FAPI uptake may serve as an imaging biomarker for cardiac remodeling. Further studies are warranted to clarify the role of 18 F-FAPI PET in evaluating the efficacy of anti-fibrotic treatment and in assisting cardiac risk stratification in ESRD patients.
- Open Access
- 3 September 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1785331
A deep transfer learning radiomics nomogram using chest CT for differentiating anterior mediastinal cysts from low-grade thymomas
Objectives: The objective of this study was to develop a nomogram by integrating clinical features, radiomics predictive results, and deep transfer learning (DTL) predictive results to differentiate between anterior mediastinal cysts (AMCs) and low-grade thymomas. Methods: The training set included 149 cases of AMCs and low-grade thymomas, whereas the test set included 49 cases of AMCs and low-grade thymomas. Contrast-enhanced chest CT images were used for analysis. A deep transfer learning radiomics (DTLR) nomogram was developed by integrating selected clinical features, radiomics predictive results, and DTL predictive results. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) curves were subsequently plotted. Results: This study identified clinical features, including maximum diameter, primary site, and relation to surroundings, to construct a clinical model. The DTLR nomogram demonstrated optimal predictive performance in the test set, achieving an area under the receiver operating characteristic curve (AUC) of 0.965, an accuracy of 0.857, a sensitivity of 0.895, and a specificity of 0.833. DCA demonstrated that DTLR is not optimal and is not significantly different from DTL. The DeLong test confirmed statistically significant differences in predictive performance between the DTLR nomogram and both the clinical model and the radiomics model, whereas no significant intermodal differences were observed among the other comparative approaches. DCA indicated that the predictive value of the DTLR nomogram was comparable to that of the DTL model. However, the DTLR nomogram demonstrated superior performance in the DeLong test, suggesting its potential as an effective clinical decision-support tool. Conclusions: Although further validation is needed before clinical implementation, the DTLR nomogram demonstrated favorable predictive performance and showed promise as a practical tool for clinical decision-making.
- 3 September 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1785331
Open AccessA deep transfer learning radiomics nomogram using chest CT for differentiating anterior mediastinal cysts from low-grade thymomas
Objectives: The objective of this study was to develop a nomogram by integrating clinical features, radiomics predictive results, and deep transfer learning (DTL) predictive results to differentiate between anterior mediastinal cysts (AMCs) and low-grade thymomas. Methods: The training set included 149 cases of AMCs and low-grade thymomas, whereas the test set included 49 cases of AMCs and low-grade thymomas. Contrast-enhanced chest CT images were used for analysis. A deep transfer learning radiomics (DTLR) nomogram was developed by integrating selected clinical features, radiomics predictive results, and DTL predictive results. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) curves were subsequently plotted. Results: This study identified clinical features, including maximum diameter, primary site, and relation to surroundings, to construct a clinical model. The DTLR nomogram demonstrated optimal predictive performance in the test set, achieving an area under the receiver operating characteristic curve (AUC) of 0.965, an accuracy of 0.857, a sensitivity of 0.895, and a specificity of 0.833. DCA demonstrated that DTLR is not optimal and is not significantly different from DTL. The DeLong test confirmed statistically significant differences in predictive performance between the DTLR nomogram and both the clinical model and the radiomics model, whereas no significant intermodal differences were observed among the other comparative approaches. DCA indicated that the predictive value of the DTLR nomogram was comparable to that of the DTL model. However, the DTLR nomogram demonstrated superior performance in the DeLong test, suggesting its potential as an effective clinical decision-support tool. Conclusions: Although further validation is needed before clinical implementation, the DTLR nomogram demonstrated favorable predictive performance and showed promise as a practical tool for clinical decision-making.
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
Incremental value of coronary computed tomography (CT) angiography-based coronary artery disease-reporting and data system score and CT-derived translesional fractional flow reserve gradient across the lesion with the highest-grade stenosis to the cardiovascular risk in orthotopic liver transplantation score in predicting major adverse cardiovascular events after liver transplantation
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
Incremental value of coronary computed tomography (CT) angiography-based coronary artery disease-reporting and data system score and CT-derived translesional fractional flow reserve gradient across the lesion with the highest-grade stenosis to the cardiovascular risk in orthotopic liver transplantation score in predicting major adverse cardiovascular events after liver transplantation
- 24 June 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (11) , 2053-2065
Incremental prognostic value of CCTA-based myocardial radiomics over clinical factors, anatomic and hemodynamic CTA findings in patients with stable angina
The aim of this study was to investigate additional risk stratification benefits of myocardial radiomics derived from coronary CTA (CCTA) over clinical factors, anatomic and hemodynamic CTA findings in patients with stable angina. 2171 multicenter patients with stable angina who underwent CCTA were retrospectively included. The endpoints were major adverse cardiovascular events (MACE). Clinical factors and CTA findings were analyzed to identify the independent predictors. The left ventricular myocardium was segmented from CCTA, and the radiomics features were assessed to build a radiomics signature (RS). A radiomics nomogram (RN) was constructed by combining the independent clinical and CTA predictors with the RS. Previous myocardial infarction, hyperlipidemia, and the change in CT derived fractional flow reserve (ΔFFRCT) were proven as independent predictors for MACE (C-index, 0.733, test cohort). The RS was significantly associated with MACE (C-index, 0.713, test cohort). By adding the RS to the clinical and CTA predictors, the RN provided a higher C-index (0.788, test cohort), and higher time-AUCs. In the test cohort, the IDIs of RN to the clinical and CTA predictors were 3.10% (95% CI, 0.50–5.60%, P = 0.004), and 5.40% (95% CI, 0.40–10.30%, P = 0.040) for 1-year and 3-year MACE, respectively. In subgroup analyses in patients with diabetes mellitus and hypertension, the RS had additional predictive value for MACE over the clinical and CTA findings. Compared to clinical factors, anatomic and hemodynamic CTA findings, CCTA-derived myocardial radiomics provides incremental prognostic value for the prediction of MACE in patients with stable angina. Graphical abstract
- 24 June 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (11) , 2053-2065
Incremental prognostic value of CCTA-based myocardial radiomics over clinical factors, anatomic and hemodynamic CTA findings in patients with stable angina
The aim of this study was to investigate additional risk stratification benefits of myocardial radiomics derived from coronary CTA (CCTA) over clinical factors, anatomic and hemodynamic CTA findings in patients with stable angina. 2171 multicenter patients with stable angina who underwent CCTA were retrospectively included. The endpoints were major adverse cardiovascular events (MACE). Clinical factors and CTA findings were analyzed to identify the independent predictors. The left ventricular myocardium was segmented from CCTA, and the radiomics features were assessed to build a radiomics signature (RS). A radiomics nomogram (RN) was constructed by combining the independent clinical and CTA predictors with the RS. Previous myocardial infarction, hyperlipidemia, and the change in CT derived fractional flow reserve (ΔFFRCT) were proven as independent predictors for MACE (C-index, 0.733, test cohort). The RS was significantly associated with MACE (C-index, 0.713, test cohort). By adding the RS to the clinical and CTA predictors, the RN provided a higher C-index (0.788, test cohort), and higher time-AUCs. In the test cohort, the IDIs of RN to the clinical and CTA predictors were 3.10% (95% CI, 0.50–5.60%, P = 0.004), and 5.40% (95% CI, 0.40–10.30%, P = 0.040) for 1-year and 3-year MACE, respectively. In subgroup analyses in patients with diabetes mellitus and hypertension, the RS had additional predictive value for MACE over the clinical and CTA findings. Compared to clinical factors, anatomic and hemodynamic CTA findings, CCTA-derived myocardial radiomics provides incremental prognostic value for the prediction of MACE in patients with stable angina. Graphical abstract
- Open Access
- 11 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Perivascular fat attenuation index on coronary computed tomography angiography predicts postoperative atrial fibrillation after off-pump coronary artery bypass grafting
Postoperative atrial fibrillation (POAF) is a prevalent complication following cardiac surgery, which has been associated with inflammatory activity in epicardial adipose tissue. There is a lack of effective means for its prediction and prevention. The fat attenuation index (FAI) serves as a non-invasive imaging biomarker capable of quantifying pericoronary adipose tissue inflammation. In this retrospective study, patients who underwent off-pump coronary artery bypass grafting (OPCABG) and had preoperative coronary computed tomography angiography (CCTA) were included. The pericoronary FAI was measured from CCTA images. POAF was identified based on ECG monitoring within 7 days after surgery. A multivariate logistic regression model incorporating variables significant in univariate analysis and clinically relevant factors was constructed. Model performance with and without FAI was compared using the area under the curve (AUC) with DeLong's test. A total of 140 patients were finally included, including 41 patients (29.2%) in the POAF group and 99 patients (70.8%) in the NO-POAF group Multivariate logistic regression identified hypertension and a higher FAI around the right coronary artery as independent predictors of POAF, while history of myocardial infarction showed a trend toward significance. The inclusion of FAI (RCA) significantly improved model discrimination (AUC increased from 0.711 for the clinical model to 0.752; DeLong p = 0.049). The pericoronary FAI, particularly around the RCA, provides incremental predictive information and may help identify patients at elevated POAF risk; however, its precise clinical utility requires further validation.
- 11 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessPerivascular fat attenuation index on coronary computed tomography angiography predicts postoperative atrial fibrillation after off-pump coronary artery bypass grafting
Postoperative atrial fibrillation (POAF) is a prevalent complication following cardiac surgery, which has been associated with inflammatory activity in epicardial adipose tissue. There is a lack of effective means for its prediction and prevention. The fat attenuation index (FAI) serves as a non-invasive imaging biomarker capable of quantifying pericoronary adipose tissue inflammation. In this retrospective study, patients who underwent off-pump coronary artery bypass grafting (OPCABG) and had preoperative coronary computed tomography angiography (CCTA) were included. The pericoronary FAI was measured from CCTA images. POAF was identified based on ECG monitoring within 7 days after surgery. A multivariate logistic regression model incorporating variables significant in univariate analysis and clinically relevant factors was constructed. Model performance with and without FAI was compared using the area under the curve (AUC) with DeLong's test. A total of 140 patients were finally included, including 41 patients (29.2%) in the POAF group and 99 patients (70.8%) in the NO-POAF group Multivariate logistic regression identified hypertension and a higher FAI around the right coronary artery as independent predictors of POAF, while history of myocardial infarction showed a trend toward significance. The inclusion of FAI (RCA) significantly improved model discrimination (AUC increased from 0.711 for the clinical model to 0.752; DeLong p = 0.049). The pericoronary FAI, particularly around the RCA, provides incremental predictive information and may help identify patients at elevated POAF risk; however, its precise clinical utility requires further validation.
- 26 May 2026
- Published by Elsevier in Clinical Radiology
- Vol. 99, 107397
Effect of myocardial bridging on the fat attenuation index of proximal coronary arteries: a dual-centre study in a plaque-free population
- 26 May 2026
- Published by Elsevier in Clinical Radiology
- Vol. 99, 107397
Effect of myocardial bridging on the fat attenuation index of proximal coronary arteries: a dual-centre study in a plaque-free population
- Open Access
- 7 May 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Multimodal radiomics incorporating intratumoral heterogeneity for prognostic assessment of metastatic outcomes in invasive breast cancer
This study aimed to develop prognostic models of distant metastasis (DM) and bone metastasis (BM) in invasive breast cancer (IBC) incorporating whole-tumor
- 7 May 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Open AccessMultimodal radiomics incorporating intratumoral heterogeneity for prognostic assessment of metastatic outcomes in invasive breast cancer
This study aimed to develop prognostic models of distant metastasis (DM) and bone metastasis (BM) in invasive breast cancer (IBC) incorporating whole-tumor
- 23 April 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (8) , 3350-3359
Combining Coronary CTA Features with Clinical Risk Factors for Predicting Adverse Clinical Outcomes Following Transcatheter Aortic Valve Replacement
- 23 April 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (8) , 3350-3359
Combining Coronary CTA Features with Clinical Risk Factors for Predicting Adverse Clinical Outcomes Following Transcatheter Aortic Valve Replacement
- 1 April 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (9) , 5263-5276
Al18F-NOTA-HER2-BCH PET/MR for regional lymph node metastasis assessment in HER2-low and -positive breast cancer: a prospective study
- 1 April 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (9) , 5263-5276
Al18F-NOTA-HER2-BCH PET/MR for regional lymph node metastasis assessment in HER2-low and -positive breast cancer: a prospective study
- 1 November 2025
- Published by Springer Nature in European Radiology
- Vol. 36 (4) , 3170-3183
Combination of dual-energy CT findings and clinical features predicts risk of frequent flares of gout
Objectives To develop and validate a model that integrates dual-energy computed tomography (DECT) and clinical features for the prediction of the risk of frequent gout flares (FrGF). Materials and methods This retrospective cohort study included 1204 patients with gout who were randomly divided into training and validation cohorts and followed for 12 months after DECT. The patients were categorized into an FrGF group (≥ 2 flares, n = 606) and an infrequent gout flares (InGF) group (< 2 flares, n = 598) based on flare frequency during follow-up. Clinicoradiological features that were significant in univariate analysis were dimensionally reduced via least absolute shrinkage and selection operator regression, followed by multivariate logistic regression to identify independent risk factors for FrGF. An integrated clinicoradiological model was constructed using a nomogram. Model performance was evaluated using the receiver-operating characteristic (ROC) curve and clinical utility by decision curve analysis. The integrated model was compared with the clinical model using the DeLong test to evaluate the incremental value of radiological features. Results Independent risk factors for FrGF were chronic arthritis, recurrent gout at baseline, intermittent medication, non-adherence to a low-purine diet, high monosodium urate burden, elevated Sharp/van der Heijde score, and tarsal bone erosion. The integrated model had an area under the ROC curve (AUC) of 0.95 (95% CI 0.92–0.97) in the validation cohort, outperforming the clinical model (AUC 0.83, 95% CI 0.79–0.87), demonstrating the incremental diagnostic value of DECT. Conclusion The integrated model demonstrated excellent discriminative ability, calibration, and clinical value, enabling accurate prediction of the risk of FrGF. Key Points Question Frequent gout and infrequent gout differ in treatment strategies, but how can clinicians prospectively and accurately identify frequent gout? Findings Based on clinical and DECT features, this study identified 7 independent risk factors for frequent gout and developed and validated a predictive model. Clinical relevance This study’s predictive model exhibits favorable predictive performance, and its web-based calculator helps clinicians assess the risk of frequent gout flares and predict clinical intervention efficacy, thus providing valuable evidence for formulating individualized clinical treatment plans. Graphical Abstract
- 1 November 2025
- Published by Springer Nature in European Radiology
- Vol. 36 (4) , 3170-3183
Combination of dual-energy CT findings and clinical features predicts risk of frequent flares of gout
Objectives To develop and validate a model that integrates dual-energy computed tomography (DECT) and clinical features for the prediction of the risk of frequent gout flares (FrGF). Materials and methods This retrospective cohort study included 1204 patients with gout who were randomly divided into training and validation cohorts and followed for 12 months after DECT. The patients were categorized into an FrGF group (≥ 2 flares, n = 606) and an infrequent gout flares (InGF) group (< 2 flares, n = 598) based on flare frequency during follow-up. Clinicoradiological features that were significant in univariate analysis were dimensionally reduced via least absolute shrinkage and selection operator regression, followed by multivariate logistic regression to identify independent risk factors for FrGF. An integrated clinicoradiological model was constructed using a nomogram. Model performance was evaluated using the receiver-operating characteristic (ROC) curve and clinical utility by decision curve analysis. The integrated model was compared with the clinical model using the DeLong test to evaluate the incremental value of radiological features. Results Independent risk factors for FrGF were chronic arthritis, recurrent gout at baseline, intermittent medication, non-adherence to a low-purine diet, high monosodium urate burden, elevated Sharp/van der Heijde score, and tarsal bone erosion. The integrated model had an area under the ROC curve (AUC) of 0.95 (95% CI 0.92–0.97) in the validation cohort, outperforming the clinical model (AUC 0.83, 95% CI 0.79–0.87), demonstrating the incremental diagnostic value of DECT. Conclusion The integrated model demonstrated excellent discriminative ability, calibration, and clinical value, enabling accurate prediction of the risk of FrGF. Key Points Question Frequent gout and infrequent gout differ in treatment strategies, but how can clinicians prospectively and accurately identify frequent gout? Findings Based on clinical and DECT features, this study identified 7 independent risk factors for frequent gout and developed and validated a predictive model. Clinical relevance This study’s predictive model exhibits favorable predictive performance, and its web-based calculator helps clinicians assess the risk of frequent gout flares and predict clinical intervention efficacy, thus providing valuable evidence for formulating individualized clinical treatment plans. Graphical Abstract